How are clinical trials evolving in MDS?💭

At #iwMDS25, leading experts Maximilian Stahl, Rami Komrokji, & Coleman Lindsley discussed redefining response criteria & improving study design to advance care.🩸

Don’t miss this insightful session:

🎥 👉 buff.ly/cj2cXpS

#MDSsm #HemOnc #CTSM #BloodSky

At #iwMDS25, leading experts @abrunner.bsky.social, @mikkaelsekeres.bsky.social, & Lionel Ades shared insights into recent advances in the treatment & management of LR-MDS.🩸

Check out the roundtable discussion here:

👉 buff.ly/SkpE0p4 👈

#MDSsm #HemOnc #BloodSky #HemeSky #MedSky

Want to hear about updates & advances in MDS classification & risk stratification?🩸

Watch our fantastic roundtable discussion from #iwMDS25 with experts Uma Borate, Luca Lanino, Robert Hasserjian, & @zoeyxie.bsky.social:

🎥 buff.ly/Yr2mKl8

#MDSsm #HemOnc #BloodSky #HemeSky #MedSky

Want to hear about updates & advances in MDS classification & risk stratification?🩸

Watch our fantastic roundtable discussion from #iwMDS25 with experts Uma Borate, Luca Lanino, Robert Hasserjian, & Zhuoer Xie:

🎥 buff.ly/UtUKM0w

#MDSsm #HemOnc #BloodSky #HemeSky #MedSky